ArticleThe Journal of clinical investigation2013

Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.

Natividad Pozo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.